Nps Pharmaceuticals Company Profile

Aggregated data from the web about Nps Pharmaceuticals

Company Name	Nps Pharmaceuticals
Website	https://www.marketscreener.com
Snippet	NPS PHARMACEUTICALS : Shire shares jump as drug approval vindicates $5.2 billion NPS purch.. NPS PHARMACEUTICALS : FDA Approves Natpara® (parathyroid hormone) for Injection as an Adju.. NPS PHARMACEUTICALS : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The ..
Fate	Acquired by Takeda
ISIN	JE00B2QKY057
Parent	Takeda Pharmaceutical Company (2019)
Defunct	2019
Founded	1986
Revenue	$15,160.6 million (2017)[1]
Website	www.shire.com
Industry	Pharmaceuticals
Traded as	NASDAQ: SHPG
Key people	Flemming Ornskov (CEO)Thomas Dittrich (CFO)
Net income	$4,271.5 million (2017)[1]
Former type	Subsidiary
Predecessor	Shire Pharmaceuticals Group Plc
Operating income	$2,455.2 million (2017)[1]
Number of employees	23,044 (2018)[2]

Nps Pharmaceuticals is part of the United Kingdom company list

Nps Pharmaceuticals is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.